Skip to main content

Table 6 Biometric, lipoprotein profile distributions, assessment- insulin resistance and blood glucose distributions in relation to the PPARγ C161→T genotypes in CAD with T2DM patients

From: PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus

  PPARγ genotypes
groups CC (n = 197) CT (n = 95) TT (n = 11) CT+TT (n = 106)
Age 62.64 ± 11.22 63.00 ± 12.87 66.00 ± 11.33 63.49 ± 12.61
Weight (kg) 64.35 ± 11.09 * 60.82 ± 9.16* 61.21 ± 7.31 61.38 ± 9.24
Height (m) 1.64 ± 0.09 1.63 ± 0.07 1.64 ± 0.07 1.63 ± 0.07
BMI (kg/m2) 23.94 ± 5.50 22.57 ± 3.62 24.06 ± 3.22 22.82 ± 3.58
TC (mmol/L) 4.66 ± 1.09 4.54 ± 1.17 4.19 ± 0.68 4.48 ± 1.11
Trig (mmol/L) 2.52 ± 1.59 * 1.68 ± 0.96 * 1.64 ± 0.46 1.67 ± 0.89*
HDL (mmol/L) 1.21 ± 0.38 1.22 ± 0.43 1.22 ± 0.24 1.22 ± 0.41
LDL (mmol/L) 2.74 ± 0.73 2.73 ± 0.91 2.38 ± 0.86 2.68 ± 0.90
apoA1 (g/L) 1.27 ± 0.19 1.25 ± 0.24 1.26 ± 0.10 1.25 ± 0.22
apoB (g/L) 1.02 ± 0.22* 0.94 ± 0.24* 0.94 ± 0.19 0.94 ± 0.23*
Lp(a) (mg/L) Δ 1.82 ± 0.52 1.82 ± 0.53 1.32 ± 0.22 1.75 ± 0.53
FBS (mmol/L) 6.80 ± 2.26 7.32 ± 2.81 7.24 ± 2.49 7.23 ± 2.74
PPBS (mmol/L) 9.58 ± 3.90 10.73 ± 4.83 10.37 ± 4.36 10.67 ± 4.73
RI Δ 1.42 ± 0.38 1.48 ± 0.42 1.34 ± 0.37 1.45 ± 0.41
  1. * p < 0.05. P values were obtained by ANOVA F tests for comparisons among CC, CT and TT genotypes or Student t test for comparisons between CC genotype and T allele carriers (CT+TT genotypes).
  2. Δ The measurement material were descriptive statistics of skewed distribution, and counted after logarithm